Non-Celiac Gluten Sensitivity (NCGS): Biomarkers, Exclusions, and Clinical Investigation Pathways
What Is Non-Celiac Gluten Sensitivity?
Non-celiac gluten sensitivity (NCGS) is a clinical condition in which individuals experience gastrointestinal and systemic symptoms in response to gluten ingestion, in the absence of coeliac disease or wheat allergy. Symptoms may include bloating, fatigue, brain fog, and abdominal discomfort, typically resolving when gluten is removed from the diet.
Unlike coeliac disease, NCGS does not involve the autoimmune destruction of the intestinal lining, nor does it produce the same serological antibody profile. It is, however, a recognised and increasingly investigated clinical entity within UK gastroenterology and allergy practice.
For many individuals across London and the wider UK, understanding whether their symptoms relate to NCGS — rather than to coeliac disease or wheat allergy — requires a structured exclusion and investigation pathway, often beginning with targeted blood screening.
Practical Insight: NCGS remains a diagnosis of exclusion. Identifying what a person does not have (coeliac disease, wheat allergy) is as clinically meaningful as exploring what they do have.
NCGS vs Coeliac Disease vs Wheat Allergy: Understanding the Differences
One of the most important steps in any clinical investigation pathway for gluten-related symptoms is accurate differentiation. These three conditions are frequently confused, yet they have distinct mechanisms, biomarkers, and implications.
| Feature | Coeliac Disease | Wheat Allergy | Non-Celiac Gluten Sensitivity |
|---|---|---|---|
| Immune Mechanism | Autoimmune (T-cell mediated) | IgE-mediated allergic response | Innate immune activation (proposed) |
| Intestinal Damage | Yes (villous atrophy) | No | No |
| Key Antibodies | tTG-IgA, EMA-IgA | Wheat-specific IgE | Anti-gliadin IgG (some cases) |
| Genetic Markers | HLA-DQ2/DQ8 (90%+) | Not reliably associated | Partial HLA-DQ2 association possible |
| Response to Gluten Removal | Yes | Yes (to wheat) | Yes |
| Definitive Diagnostic Test | Biopsy (via gastroenterology) | Skin prick / specific IgE | Exclusion (no confirmatory test) |
| Prevalence (UK estimate) | ~1% | ~0.1–0.5% | ~1–6% (emerging data) |
Practical Insight: Because no single biomarker confirms NCGS, investigation pathways focus on systematically ruling out coeliac disease and wheat allergy before NCGS is considered a likely explanation for symptoms.
Key Biomarkers Used in the Investigation Pathway
Tissue Transglutaminase IgA (tTG-IgA)
This is the primary serological marker used to screen for coeliac disease. Elevated tTG-IgA may indicate an autoimmune response to gluten in individuals with intact IgA production. A normal tTG-IgA result in a person consuming gluten is a key step in excluding coeliac disease before NCGS is considered.
Total Serum IgA
Total IgA is measured alongside tTG-IgA because selective IgA deficiency — present in approximately 1 in 400 people — can produce a falsely negative tTG-IgA. When total IgA is low, IgG-based coeliac antibody tests may be more appropriate.
Deamidated Gliadin Peptide (DGP) Antibodies (IgA and IgG)
DGP antibodies, particularly DGP-IgG, can be useful when total IgA is deficient or when tTG-IgA is borderline. Some research also suggests elevated DGP-IgG may appear in a subset of NCGS individuals, though this finding is not yet confirmatory.
Anti-Gliadin Antibodies (AGA IgG/IgA)
Older gliadin antibody tests (AGA) have lower specificity for coeliac disease but may be used in the context of NCGS investigation as part of a broader panel. Some NCGS patients show elevated AGA-IgG without meeting criteria for coeliac disease.
Wheat-Specific IgE
When wheat allergy is a clinical possibility — particularly where symptoms are rapid-onset, urticarial, or respiratory — wheat-specific IgE measurement helps exclude an IgE-mediated allergic reaction from the diagnostic picture.
Full Blood Count and Ferritin
Nutritional markers, including haemoglobin and ferritin, can sometimes highlight the downstream effects of ongoing gastrointestinal inflammation or malabsorption. Low ferritin in particular may accompany undiagnosed coeliac disease, though it is not specific to gluten-related conditions.
Practical Insight: No single biomarker confirms NCGS in isolation. The value of structured screening lies in the systematic exclusion of other conditions and in providing objective data to support further clinical assessment.
Who Should Consider NCGS Investigation?
Individuals who may benefit from structured gluten-sensitivity investigation include those who:
- Experience persistent bloating, fatigue, or brain fog that they associate with eating gluten-containing foods
- Have already trialled a short gluten-free period and noticed symptomatic improvement
- Have not previously been formally screened for coeliac disease or wheat allergy
- Have a first-degree relative with diagnosed coeliac disease
- Present with unexplained fatigue, low mood, or joint discomfort alongside digestive symptoms
- Are consuming a gluten-containing diet at the time of testing (essential for accurate antibody results)
It is important to note that antibody tests for coeliac disease require gluten to be present in the diet at the time of testing. Individuals who have already adopted a gluten-free diet before testing may receive falsely negative antibody results.
Our clinic in London offers food intolerance and allergy blood testing for individuals who wish to investigate potential gluten-related symptoms through objective laboratory analysis.
How Often Should Testing Be Considered?
For initial investigation, a structured one-off panel — covering coeliac antibodies, total IgA, wheat-specific IgE, and supporting markers — is typically sufficient to begin the exclusion pathway.
Repeat testing may be considered if:
- Symptoms persist or change significantly over time
- A previously gluten-free individual reintroduces gluten and wishes to rescreen
- Initial results were borderline and clinical symptoms remain unexplained
- Dietary changes or health status have evolved since the last screen
For those managing ongoing dietary exclusions or monitoring nutritional status, periodic screening of markers such as ferritin, B12, and full blood count may provide useful contextual data. You can explore our health screening options to find panels relevant to your needs.
Understanding Your Results: What the Data Can Suggest
Receiving blood test results is an informative step — but results are best understood within the broader clinical picture, not in isolation.
- Elevated tTG-IgA may suggest an autoimmune response consistent with coeliac disease and warrants follow-up with an appropriate healthcare professional
- Normal tTG-IgA with ongoing symptoms may suggest coeliac disease is less likely, keeping NCGS or wheat sensitivity in the differential
- Elevated wheat-specific IgE may indicate an IgE-mediated wheat allergy rather than gluten sensitivity
- Raised DGP-IgG with normal tTG-IgA may warrant further clinical discussion, particularly if IgA deficiency is present
- Normal results across all markers may suggest gluten-related immune activity is not the primary driver of symptoms, encouraging exploration of alternative causes
As a nurse-led screening clinic, we provide detailed written reports to help you understand your results clearly. We report findings only and do not offer diagnosis, prescriptions, or treatment. We always encourage individuals to share results with an appropriate healthcare professional for clinical interpretation and next steps.
Practical Insight: Knowing what your antibody markers show — even when results are within normal ranges — is genuinely useful clinical information that supports informed conversations with healthcare providers.
NCGS Investigation in a London Private Screening Context
Access to private health screening in London has expanded significantly, with many individuals choosing to investigate symptoms proactively rather than waiting for NHS referral pathways, which may involve longer timescales.
For gluten-related symptoms specifically, private blood testing can:
- Provide a baseline antibody profile before a GP or gastroenterology appointment
- Confirm or reassure regarding coeliac disease risk before a dietary change is made
- Support individuals who have already consulted clinically but wish to monitor over time
It is worth noting that NHS coeliac disease testing follows established NICE guidance (CG86) and remains the gold standard for formal diagnosis. Private screening serves a complementary, informational role and does not replace NHS diagnostic processes or specialist assessment.
Our London allergy clinic provides accessible, nurse-led blood testing in a professional clinical environment, with results reported clearly and confidentially.
Frequently Asked Questions About Non-Celiac Gluten Sensitivity Testing
1. What is non-celiac gluten sensitivity, and how is it different from coeliac disease?
NCGS involves gluten-related symptoms without the autoimmune intestinal damage seen in coeliac disease. No single confirmatory biomarker exists for NCGS; it is identified through exclusion of coeliac disease and wheat allergy, typically via a structured blood testing pathway.
2. Can a blood test diagnose non-celiac gluten sensitivity?
Currently, no blood test can confirm NCGS definitively. However, blood testing can exclude coeliac disease and wheat allergy — which are essential steps in any clinical investigation pathway before NCGS is considered a likely explanation for symptoms.
3. Do I need to be eating gluten before a non-celiac gluten sensitivity blood test?
Yes. Coeliac antibody tests require gluten to be present in the diet to produce accurate results. Individuals following a gluten-free diet before testing may receive falsely negative antibody findings.
4. What biomarkers are typically included in a gluten sensitivity investigation panel?
A structured panel may include tTG-IgA, total serum IgA, deamidated gliadin peptide antibodies (DGP IgA/IgG), anti-gliadin antibodies (AGA IgG), and wheat-specific IgE, alongside supporting markers such as full blood count and ferritin.
5. What does a normal coeliac antibody result mean if I still have symptoms?
Normal antibody levels may suggest coeliac disease is less likely, but they do not explain the cause of ongoing symptoms. NCGS, irritable bowel syndrome (IBS), other food intolerances, and several other conditions can produce similar symptoms and may warrant separate investigation.
6. Is NCGS testing available privately in London?
Yes. Private nurse-led clinics in London, including our allergy screening service, offer gluten-related antibody panels. Results are reported in detail and can support informed conversations with your GP or a relevant healthcare professional.
7. How long does it take to receive blood test results?
Turnaround times vary depending on the laboratory and the specific tests requested. Our clinic provides written reports as promptly as possible, and our team is available to discuss your results report once received.
8. Can children be tested for gluten sensitivity?
Blood testing for gluten-related markers can be relevant for children experiencing persistent symptoms. However, paediatric assessment and clinical oversight remain essential. We recommend consulting an appropriate healthcare professional before arranging testing for children.
9. What should I do with my test results once I receive them?
We recommend sharing your results with your GP or an appropriate healthcare professional who can contextualise the findings within your full medical history and advise on any next steps.
10. Does your clinic offer treatment or dietary advice for gluten sensitivity?
Our clinic provides testing and reporting services only. We do not offer prescriptions, treatment plans, or dietary therapy. We always recommend consulting a qualified healthcare professional for clinical interpretation and management guidance.
Take a Proactive Step Towards Understanding Your Health
If you have been experiencing digestive discomfort, persistent fatigue, or other symptoms you associate with gluten, exploring your biomarker profile through structured blood testing can be a meaningful and informative first step.
Our nurse-led allergy and health screening clinic in London offers a professional, confidential testing environment. Visit our allergy testing page to explore available screening options, or contact our clinic to discuss your requirements with our team.
Understanding your body begins with the right questions — and structured testing can help provide objective answers.
EEAT Authority Statement
This article has been produced by the editorial team at The Allergy Clinic, a UK-based nurse-led health screening service. Content is developed in alignment with NHS NICE guidance, published clinical literature on gluten-related conditions, and UK medical editorial best practice. All information is reviewed for accuracy, balance, and compliance with GMC advertising guidance, CQC patient communication standards, and ASA guidelines. This clinic provides testing and reporting services only and does not offer diagnosis, treatment, or prescription services.
Disclaimer
This article is intended for educational and informational purposes only. The content does not constitute medical advice, diagnosis, or a treatment plan. Individual symptoms, health concerns, or blood test results should always be assessed by an appropriately qualified healthcare professional in the context of your full clinical history. The Allergy Clinic provides testing and reporting services only; we do not diagnose conditions, prescribe medications, or offer therapeutic interventions. If you are experiencing severe, worsening, or urgent symptoms, please seek appropriate medical care promptly. Results from private blood testing are informational and complement — but do not replace — NHS clinical assessment and professional medical guidance.
